Editorial: Shiga Toxin-Converting Bacteriophages

Abstract

Editorial on the Research Topic Shiga Toxin-Converting Bacteriophages Shiga toxin-producing Escherichia coli (STEC) strains, and particularly a subset of this group of bacteria called enterohemorrhagic E. coli (EHEC), are dangerous human pathogens (Newell and La Ragione, 2018). They cause bloody diarrhea and some other symptoms, but the most severe complication, causing the death of a relatively large fraction of patients, is hemolytic uremic syndrome (Karmali, 2018; Joseph et al., 2020). The major virulence factors of STEC are Shiga toxins that are complex proteins (composed of one A and five B subunits; AB₅) which enter an eukaryotic cell mainly through the interaction of the toxin B subunit with the Gb3 and/or Gb4 receptor. After endocytosis, followed by retro-translocation from the Golgi apparatus and endoplasmic reticulum, the toxin A subunit, which is an actual toxin, is released into the cytoplasm where it inactivates ribosomes by specific cleavage of one of the adenine residues in 28S rRNA (Menge, 2020). The crucial point of virulence of STEC is the fact that Shiga toxins are not encoded in E. coli chromosomes but their genes, called stx genes, are located in the genomes of bacteriophages which occur in their hosts as prophages (Loś et al., 2011). These bacteriophages, called also Stx phages, belong to the group of lambdoid phages. After infection, Stx phages may lysogenize the host cell. Following integration of the phage DNA into the bacterial chromosome, it can be passively replicated together with the host genome. In lysogenic cells, the vast majority of phage genes are silent, including stx genes. Under conditions causing the appearance of single-stranded DNA fragments which induce the bacterial S.O.S. response, the phage-encoded major repressor (the cI protein) is cleaved. This leads to induction of the prophage, excision of phage DNA, and subsequent lytic development which consists of effective viral DNA replication, production of progeny virions, and their release after host cell lysis. This is accompanied with massive production and liberation of Shiga toxins. Although under laboratory conditions, UV irradiation or DNA-binding antibiotics, like mitomycin C, are routinely used to activate the S.O.S. response, it appears that oxidative stress may be one of major causes of Stx prophage induction in STEC-infected humans (Licznerska et al., 2016). Importantly, contrary to early predictions of uniformity in Stx phages, this group of viruses has been recognized as highly variable (Krüger and Lucchesi, 2015). An E. coli host can be lysogenized not only by one, but also by two or more Stx phages which may result in the production of different types of Stx toxins in one bacterial cell. In fact, it was demonstrated that understanding the biodiversity and evolution of Stx phages may have a great impact on both the accurate diagnostics of STEC-mediated infections and development of novel therapeutic approaches (Martínez-Castillo and Muniesa, 2014). The treatment of STEC-infected patients is particularly difficult as it was found that many antibiotics are potent inducers of prophages. Therefore, even if antibiotic treatment can kill bacterial cells or inhibit their growth, prophage induction would cause effective production of Shiga toxin in the meantime which could be more dangerous for patients than the presence of STEC cells. Although some antibiotics can kill bacteria without stimulating the S.O.S. response, the use of antibiotics in the treatment of STEC infections remains controversial (Bielaszewska et al., 2012). Such a medical procedure is formally forbidden in some countries if this type of disease is confirmed or even suspected (Kakoullis et al., 2019). In this light, development of alternative therapies appears crucial (Mühlen and Dersch, 2020). On the other hand, effective management of diseases caused by STEC requires an understanding of the details of pathogenicity mechanisms and epidemiology, and development of rapid and accurate diagnostic methods (Paletta et al., 2020). Cattle are considered to be the main reservoir of STEC (Kim et al., 2020). This is because bovine vascular cells do not contain the Gb3 receptor [though it may be present in some other tissues, as reported by Pruimboom-Brees et al. (2000)], therefore, Shiga toxins cannot enter them efficiently (Sapountzis et al., 2020). Nevertheless, despite enormous progress in studies on various aspects of STEC and Stx phages, it appears that we are still far from understanding the details of their diversity, evolution, distribution, and molecular mechanisms of functioning. In the light of the problems and open questions summarized above, a special issue of this journal has been devoted to present recent advances in studies on Stx phages. According to recent trends, articles published in this issue are focused on biodiversity and evolution of these phages, as well as on molecular mechanisms of their development, including genetic recombination, which seems to be of particular importance in increasing variability of viruses (general recombination) and virulence of E. coli strains (site-specific recombination). A novel view on evolution of Stx phages has been presented by Zuppi et al. They have isolated newly discovered Stx phages from STEC strains, analyzed phages' whole-genome sequences and compared them to previously sequenced genomes of other Stx phages. Considerable variability of these phages was noted, and multiple transduction events have been predicted. The crucial conclusion from this study was that “colonization of a specific reservoir by STEC strains could be influenced by the Stx phage that they carry.” This is an important contribution to our understanding of the distribution of STEC in animal carriers, and further attempts to recognize reservoirs of these bacteria more...